Body
This project is a collaborative, 3-phase, mixed-methods study to develop consensus around diagnostic and decision-making criteria for complicated UTI (cUTI) among people with SCI and the clinicians who treat them.
The Midwest Regional Spinal Cord Injury Care System at Shirley Ryan 嫩B研究院 is a participating Model Systems site.
The lead site is the .
Other participating sites are:
The project is currently enrolling (MOD0002180 IRB Approved date 5/13/2025) participants with SCI with neurogenic lower urinary tract dysfunction.
The research study is a 6-month study that includes training individuals with neurogenic lower urinary tract dysfunction (NLUTD) on:
· Urinary symptoms specific to their bladder management,
· Management of urinary symptoms, and
· Overall urinary health
Participants will learn how to improve communication with your clinician about your urinary symptoms, management, and overall health using a validated Urinary Symptom Questionnaire. Your participation can help enhance care strategies and empower you in making informed decisions about your health.
More information is available . Contact Ana Valeria Aguirre Guemez at anavaleria.aguirregumez@medstar.net or (202) 877-1875
Participants will learn how to use the cUTI Guidelines urinary symptoms decision making algorithm specific to their symptoms, and complete weekly Urinary Symptom Questionnaire for Neurogenic Bladder- USQNB surveys for a period of 6 months. After that, we will ask for a one-time survey about the impact their participation has had on their urinary health and antibiotics use.
In Phase 1 (qualitative) we will engage clinicians SCIMS-wide in focus groups to refine cUTI-related decision-making using our three reliable and validated USQNBs (Urinary Symptom Questionnaire for Neurogenic Bladder) as points of departure, and then conduct a Delphi survey to explore and achieve consensus on diagnostic criteria and guidelines for cUTI among a nationally representative sample of clinicians from the SCIMS network (PM&R, Infectious Disease, Urology, Primary Care, Emergency Medicine), the Infectious Disease Society of America (IDSA), and the Neurogenic Bladder 嫩B研究院 Group (NBRG). In Phase 2 (qualitative) we will develop and deploy training materials and a train-the-trainer program based on the SCIMS cUTI Consensus Guidelines resulting from Phase 1. Finally, in Phase 3 (quantitative) we will assess clinicians’ uptake and use of the Guidelines, and the impact of the Guidelines training on consumers’ self-management habits, engagement with the health care system, and antibiotic use, over the 12 months after training.